Conducting cancer clinical trials in the COVID-19 era (with Gary Lyman)
In this Medicine Matters oncology podcast, we speak to Gary Lyman (Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, U...
Medicine Matters oncology
Share:
Listens: 11
About
Interviews with clinical experts, discussing key issues in oncology.
The UK Coronavirus Cancer Monitoring Project: What you need to know (with Lennard Lee)
Co-project leader Lennard Lee talks about the inception and development of the initiative that will provide insight into the impact of COVID-19 on peo...
CCC19: Introducing The COVID-19 and Cancer Consortium (with Gilberto Lopes)
Gilberto Lopes (Sylvester Comprehensive Cancer Center at the University of Miami, Florida, USA), a steering committee member of CCC19, tells us about ...
COVID-19 and cancer: Changing practices to meet patient needs (with Beth Sandy)
Thoracic oncology nurse practitioner Beth Sandy explains how the coronavirus pandemic is affecting cancer patient care and how strategies such as tele...
Managing patients with genitourinary cancers in the time of COVID-19 (with Cora Sternberg)
Genitourinary oncologists Cora Sternberg (Weill Cornell Medicine, New York, USA) and Axel Merseburger (University Hospital Schleswig-Holstein, Lübeck,...
COVID-19 and cancer patient care: A lung cancer specialist’s experience (with Gilberto Lopes)
Gilberto Lopes discusses the impact of the COVID-19 pandemic on the management of patients with lung cancer and outlines the measures being implemente...
Expert comment: AMG 510 KRAS inhibitor trial results – ‘A good start’ (with Colin Lindsay)
Colin Lindsay discusses the trial results for AMG 510 – a novel inhibitor targeting the KRAS G12C mutation – in patients with locally advanced or met...
Understanding the relationship between the gut microbiome and immunotherapy (with Jennifer Wargo)
Recent research has shown an association between intestinal microbiota and response to immunotherapy in the setting of various tumor types. Listen to ...
Researcher comment: COMPARE study (with Hashim Ahmed)
Hashim Ahmed takes us through the COMPARE study – presented at NCRI 2018 – which showed that men with localized prostate cancer are willing to accept...
ALL and infection: Unpicking the connection (with Mel Greaves)
Professor Mel Greaves (Institute of Cancer Research, London, UK) discusses his proposed theory for the etiology of childhood acute lymphoblastic leuke...